1. Home
  2. CURR vs LUCD Comparison

CURR vs LUCD Comparison

Compare CURR & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Currenc Group Inc. Ordinary Shares

CURR

Currenc Group Inc. Ordinary Shares

SELL

Current Price

$1.88

Market Cap

208.8M

ML Signal

SELL

Logo Lucid Diagnostics Inc.

LUCD

Lucid Diagnostics Inc.

SELL

Current Price

$0.39

Market Cap

192.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CURR
LUCD
Founded
2013
2018
Country
Singapore
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.8M
192.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CURR
LUCD
Price
$1.88
$0.39
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
243.0K
★ 7.4M
Earning Date
12-01-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 16.67
EPS
★ N/A
N/A
Revenue
★ $46,435,412.00
$4,346,000.00
Revenue This Year
$12.39
$34.40
Revenue Next Year
N/A
$191.30
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 79.00
52 Week Low
$1.31
$0.30
52 Week High
$5.08
$1.63

Technical Indicators

Market Signals
Indicator
CURR
LUCD
Relative Strength Index (RSI) 36.11 37.89
Support Level $1.43 $0.30
Resistance Level $3.50 $0.49
Average True Range (ATR) 0.23 0.05
MACD 0.03 0.01
Stochastic Oscillator 64.18 7.13

Price Performance

Historical Comparison
CURR
LUCD

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It operates into two reportable segments, which are remittance services and sales of airtime, of which maximum revenue is generated from the Remittance segment. Geographically, the group generates the majority of its geographic revenue from Malaysia.

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Share on Social Networks: